Lazard Asset Management’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.77M | Sell |
798,758
-446,274
| -36% | -$3.78M | 0.01% | 647 |
|
|
2025
Q1 | $10M | Buy |
1,245,032
+648,643
| +109% | +$5.22M | 0.02% | 493 |
|
|
2024
Q4 | $5.36M | Buy |
596,389
+461,430
| +342% | +$4.14M | 0.01% | 628 |
|
|
2024
Q3 | $989K | Buy |
134,959
+116,093
| +615% | +$851K | ﹤0.01% | 1079 |
|
|
2024
Q2 | $107K | Buy |
+18,866
| New | +$107K | ﹤0.01% | 1733 |
|
|
2024
Q1 | – | Sell |
-8,641
| Closed | -$76K | – | 2050 |
|
|
2023
Q4 | $76K | Sell |
8,641
-46,787
| -84% | -$412K | ﹤0.01% | 1762 |
|
|
2023
Q3 | $430K | Buy |
55,428
+32,137
| +138% | +$249K | ﹤0.01% | 1185 |
|
|
2023
Q2 | $224K | Buy |
+23,291
| New | +$224K | ﹤0.01% | 1312 |
|
|
2023
Q1 | – | Sell |
-8,865
| Closed | -$38K | – | 2294 |
|
|
2022
Q4 | $38K | Sell |
8,865
-106
| -1% | -$454 | ﹤0.01% | 1921 |
|
|
2022
Q3 | $67K | Buy |
8,971
+3,671
| +69% | +$27.4K | ﹤0.01% | 1660 |
|
|
2022
Q2 | $53K | Hold |
5,300
| – | – | ﹤0.01% | 1784 |
|
|
2022
Q1 | $65K | Buy |
5,300
+3,298
| +165% | +$40.4K | ﹤0.01% | 1610 |
|
|
2021
Q4 | $45K | Buy |
+2,002
| New | +$45K | ﹤0.01% | 1781 |
|
|
2021
Q2 | – | Sell |
-3,520
| Closed | -$45K | – | 1958 |
|
|
2021
Q1 | $45K | Buy |
+3,520
| New | +$45K | ﹤0.01% | 1477 |
|